Product Images Medroxyprogesterone Acetate

This is a table displaying odds ratios and 95% confidence intervals for studies examining the association between DMPA use for 12 months or more and risk of a certain outcome. The odds ratios are displayed on a logarithmic scale and ratios greater than 1 indicate an increased risk for DMPA users. Details about the studies and the outcome studied are not available in the provided text.*

This text describes various birth control methods and their effectiveness in preventing pregnancies in women. The text presents statistics on the number of pregnancies per 100 women based on the type of birth control used. It mentions several hormonal methods such as birth control pills, skin patch, and intrauterine devices, and also describes non-hormonal methods such as condoms, diaphragms, and spermicides. Additionally, the text mentions the option of not engaging in sexual activity during the woman's most fertile days of the month or using the withdrawal method.*

This is a description of a prescription medication called medroxyPROGESTERone Acetate Injectable Suspension, USP. It has a concentration of 150 mg per mL and is intended for intramuscular use only. The medication is packaged in a single-dose prefilled syringe and should be shaken before use. It is manufactured by AUROMEDICS in India and distributed by AuroMedics Pharma LLC in E. Windsor, NJ 08520. The code P1422299 is also provided.*